Journal of Biological Chemistry · 1995 · 156 citations · 20 references
Life SciencesBiochemistryMolecular BiologyCell SignalingMolecular NeuroscienceSignal TransductionG Protein-coupled Receptor SignalingLigand BindingMembrane ReceptorsReceptor BindingReceptor-ligand InteractionsReceptor-mediated SignalingG Protein-coupled Receptor BindingG Protein-coupled SignalingG-protein-coupled ReceptorsMuscarinic Acetylcholine Receptor SignalingMuscarinic Receptor SubtypesMuscarinic ReceptorsReceptor-ligand BindingReceptors
To test the hypothesis that G protein-coupled receptors consist of multiple autonomous folding domains, the rat m3 muscarinic acetylcholine receptor was “split” in all three intracellular (i1-i3) and all three extracellular loops (o2-o4). The six resulting polypeptide pairs (Ni1•Ci1, No2•Co2, etc.) were coexpressed in COS-7 cells and studied for their ability to bind muscarinic ligands and to activate G proteins. In addition, immunocytochemical and ELISA studies were carried out to study the expression and subcellular localization of the individual receptor fragments. Interestingly, all N- and C-terminal receptor fragments studied (except Ni1, which contained only the first transmembrane domain) were found to be localized to the plasma membrane, even when expressed alone. Coexpression of three of the six polypeptide pairs, generated by splitting the m3 muscarinic receptor in the i2, o3, or i3 loop, resulted in receptor complexes (Ni2•Ci2, No3•Co3, and Ni3•Ci3, respectively), which were able to bind muscarinic agonists and antagonists with high affinity. The No3•Co3 and Ni3•Ci3 polypeptide combinations, but not the Ni2•Ci2 complex, were also able to stimulate carbachol-dependent phosphatidyl inositol hydrolysis to a similar maximum extent as the wild type m3 muscarinic receptor. These findings strongly suggest that G protein-coupled receptors are composed of several independent folding units and may shed light on the molecular mechanisms governing receptor assembly and membrane insertion. To test the hypothesis that G protein-coupled receptors consist of multiple autonomous folding domains, the rat m3 muscarinic acetylcholine receptor was “split” in all three intracellular (i1-i3) and all three extracellular loops (o2-o4). The six resulting polypeptide pairs (Ni1•Ci1, No2•Co2, etc.) were coexpressed in COS-7 cells and studied for their ability to bind muscarinic ligands and to activate G proteins. In addition, immunocytochemical and ELISA studies were carried out to study the expression and subcellular localization of the individual receptor fragments. Interestingly, all N- and C-terminal receptor fragments studied (except Ni1, which contained only the first transmembrane domain) were found to be localized to the plasma membrane, even when expressed alone. Coexpression of three of the six polypeptide pairs, generated by splitting the m3 muscarinic receptor in the i2, o3, or i3 loop, resulted in receptor complexes (Ni2•Ci2, No3•Co3, and Ni3•Ci3, respectively), which were able to bind muscarinic agonists and antagonists with high affinity. The No3•Co3 and Ni3•Ci3 polypeptide combinations, but not the Ni2•Ci2 complex, were also able to stimulate carbachol-dependent phosphatidyl inositol hydrolysis to a similar maximum extent as the wild type m3 muscarinic receptor. These findings strongly suggest that G protein-coupled receptors are composed of several independent folding units and may shed light on the molecular mechanisms governing receptor assembly and membrane insertion. G protein-coupled receptors (GPCRs)1 1The abbreviations used are: GPCRG protein-coupled receptorDMEMDulbecco's modified Eagle's mediumELISAenzyme-linked immunosorbent assayFCSfetal calf serumIP1inositol monophosphateNMSN-methylscopolaminePBSphosphate-buffered salinePCRpolymerase chain reactionPIphosphatidylinositolTM I-VIIthe seven transmembrane domains of G protein-coupled receptors. 1The abbreviations used are: GPCRG protein-coupled receptorDMEMDulbecco's modified Eagle's mediumELISAenzyme-linked immunosorbent assayFCSfetal calf serumIP1inositol monophosphateNMSN-methylscopolaminePBSphosphate-buffered salinePCRpolymerase chain reactionPIphosphatidylinositolTM I-VIIthe seven transmembrane domains of G protein-coupled receptors. are integral membrane proteins characterized by the presence of seven transmembrane helices (TM I-VII) linked by three intracellular (i1-i3) and three extracellular loops (o2-o4) (Fig. 1). The structural elements in GPCRs involved in ligand binding and G protein recognition have been mapped in considerable detail (6Dohlman H.G. Thorner J. Caron M.G. Lefkowitz R.J. Annu. Rev. Biochem. 1991; 60: 653-688Google Scholar; 23Savarese T.M. Fraser C.M. Biochem. J. 1992; 283: 1-19Google Scholar; 24Strader C.D. Fong T.M. Tota M.R. Underwood D. Dixon R.A.F. Annu. Rev. Biochem. 1994; 63: 101-132Google Scholar). In contrast, little is known about the molecular mechanisms governing proper membrane insertion and assembly (folding) of GPCRs. G protein-coupled receptor Dulbecco's modified Eagle's medium enzyme-linked immunosorbent assay fetal calf serum inositol monophosphate N-methylscopolamine phosphate-buffered saline polymerase chain reaction phosphatidylinositol the seven transmembrane domains of G protein-coupled receptors. G protein-coupled receptor Dulbecco's modified Eagle's medium enzyme-linked immunosorbent assay fetal calf serum inositol monophosphate N-methylscopolamine phosphate-buffered saline polymerase chain reaction phosphatidylinositol the seven transmembrane domains of G protein-coupled receptors. We have recently shown that muscarinic receptors (which are typical GPCRs) behave structurally in a fashion analogous to two-subunit receptors (15Maggio R. Vogel Z. Wess J. FEBS Lett. 1993; 319: 195-200Google Scholar, 16Maggio R. Vogel Z. Wess J. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3103-3107Google Scholar). When truncated m2 or m3 muscarinic receptors (containing TM I-V) were coexpressed in COS-7 cells with their corresponding C-terminal receptor segments (containing TM VI and VII), functional muscarinic receptors were obtained. Similar findings have also been described for “split”β2-adrenergic receptors coexpressed in Xenopus oocytes (11Kobilka B.K. Kobilka T.S. Daniel K. Regan J.W. Caron M.G. Lefkowitz R.J. Science. 1988; 240: 1310-1316Google Scholar). Based on these findings, we proposed that GPCRs are composed of at least two independent folding domains, one containing TM I-V and the other TM VI and VII (15Maggio R. Vogel Z. Wess J. FEBS Lett. 1993; 319: 195-200Google Scholar, 16Maggio R. Vogel Z. Wess J. Proc. Natl. Acad. Sci. U. S. A. 1993; 90: 3103-3107Google Scholar). In this study, we have tested the hypothesis that GPCRs may consist not only of two but of multiple autonomous folding units. To this goal, the rat m3 muscarinic receptor (which was used as a model system) was split in all three intracellular (i1-i3) and all three extracellular loops (o2-o4). The six resulting polypeptide pairs (Ni1•Ci1, No2•Co2, etc.; Fig. 1) were coexpressed in COS-7 cells and studied for their ability to bind muscarinic ligands and to mediate agonist-dependent stimulation of phosphatidyl inositol (PI) hydrolysis (through interaction with G proteins of the Gq/Gll family). In addition, individual receptor fragments were epitope-tagged at their N and C termini, respectively, to allow their subcellular localization to be studied by confocal immunofluorescence microscopy and a newly developed, indirect cellular ELISA system. The immunological studies showed that all N- and C-terminal receptor fragments examined (except Ni1; Fig. 1) were inserted into the plasma membrane, even when expressed alone. The results of the coexpression experiments strongly suggest that muscarinic receptors and, most likely, other GPCRs are composed of multiple structural subunits. All mutations were introduced into Rm3pcD, a mammalian expression vector containing the entire coding sequence of the rat m3 muscarinic receptor (2Bonner T.I. Buckley N.J. Young A.C. Brann M.R. Science. 1987; 237: 527-532Google Scholar), using standard polymerase chain reaction (PCR) mutagenesis techniques (9Higuchi R. Erlich H.A. PCR Technology. Stockton Press, New York1989: 61-70Google Scholar). To allow the detection of receptor protein in immunological assays, a stretch of nucleotides coding for a nine-amino acid epitope (YPYDVPDYA) (12Kolodziej P.A. Young R.A. Methods Enzymol. 1991; 194: 508-519Google Scholar) derived from the influenza virus hemagglutinin protein (HA-epitope) was inserted after the initiating Met codon (yielding Rm3pcD-N-HA) or before the translation stop codon of Rm3pcD (yielding Rm3pcD-C-HA), respectively. For the construction of truncated m3 receptors of the “N series” (Ni1-No4; Fig. 1, Table 1), stop codons (TGA) were inserted at the appropriate positions in Rm3pcD-N-HA. The newly created stop codons were linked to a unique SstI site in the 3′-untranslated region of Rm3pcD-N-HA. For the construction of truncated m3 receptors of the “C series” (Ci1-Co4; Fig. 1, Table 1), PCR primers were designed to contain a PstI site at their 5′-ends (to link the various PCR fragments to the PstI site at position 3154 of the pcD vector), followed by six bases of 5′-untranslated sequence adjacent to the ATG translation initiation codon in Rm3pcD (GTCACA) and an in-frame ATG start codon. For immunological studies, Ci3 and Co3 were epitope-tagged at their C termini by subcloning a 1.31-kilobase pair Rm3pcD-C-HA NheI-SstI restriction fragment containing the HA-epitope into these mutant constructs. The identity of the various constructs and the correctness of all PCR-derived sequences were verified by restriction endonuclease analysis and by dideoxy sequencing of the mutant plasmids.TABLE I Open table in a new tab COS-7 cells were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 10% fetal calf serum (FCS) at 37°C in a humidified 5% CO2 incubator. For transfections, 2 × 106 cells were seeded into 100-mm dishes. About 24 h later, cells were transfected with 4 μg of plasmid DNA/dish by a DEAE-dextran method (5Cullen B.R. Methods Enzymol. 1987; 152: 684-704Google Scholar). For radioligand binding studies, transfected COS-7 cells were harvested 48-72 h after transfections. Binding assays were carried out with membrane homogenates prepared from transfected COS-7 cells essentially as described (7Drje F. Wess J. Lambrecht G. Tacke R. Mutschler E. Brann M.R. J. Pharmacol. Exp. Ther. 1991; 256: 727-733Google Scholar). Samples were incubated for 3 h at 22°C in a 1-ml volume. Incubation buffer consisted of 25 mM sodium phosphate (pH 7.4) containing 5 mM MgCl2. In N-[3H]methylscopolamine ([3H]NMS, 81.4 Ci/mmol; DuPont NEN) saturation binding experiments, six different concentrations of the radioligand (range: 6.25-200 pM) were used. In competition binding studies, membrane homogenates were incubated with 200 pM [3H]NMS and 10 different concentrations of cold inhibitor. Nonspecific binding was defined as binding in the presence of 1 μM atropine. Protein concentrations were determined by the method of 3Bradford M.M. Anal. Biochem. 1976; 72: 248-254Google Scholar. Binding data were analyzed by nonlinear least squares curve-fitting procedures, using the computer program LIGAND (saturation binding data; 18Munson P.J. Rodbard D. Anal. Biochem. 1980; 107: 220-239Google Scholar) or KALEIDAGRAPH (competition binding data; Synergy Software), respectively. Transfected COS-7 cells were transferred into six-well plates (about 0.75 × 106 cells/well) about 24 h after transfections, and 3 μCi/ml of [myo-3H]inositol (20 Ci/mmol, American Radiolabeled Chemicals Inc.) was added to the growth medium. After a 24 h-labeling period, cells were washed once with 2 ml of phosphate-buffered saline (PBS) and then incubated for 20 min (room temperature) with 0.5 ml of Hank's balanced salt solution containing 20 mM HEPES and 10 mM LiCl. Following the addition of different concentrations of carbachol, cells were incubated for 1 h at 37°C. After this time, the assay medium was removed, and the reaction was stopped by adding 0.75 ml of 0.1 N NaOH, followed by a 10-min incubation at 37°C. The alkaline solution was then neutralized by adding 0.3 ml of 0.2 M formic acid, and the inositol monophosphate (IP1) fraction was isolated by anion exchange chromatography as described (1Berridge M.J. Dawson M.C. Downes C.P. Heslop J.P. Irvine R.F. Biochem. J. 1983; 212: 473-482Google Scholar) and counted on an LKB liquid scintillation counter. An indirect cellular ELISA protocol was developed to quantify the amount of epitope-tagged receptor fragments present in the plasma membrane. One day after transfections, COS-7 cells were transferred into 96-well plates (4-5 × 104 cells/well). About 48 h later, cells were fixed with 4% formaldehyde in PBS for 30 min at room temperature. After washing with PBS and blocking with DMEM containing 10% FCS, cells were incubated for 2 h at 37°C with a monoclonal antibody directed against the HA-epitope tag (12CA5, Boehringer Mannheim; 10 μg/ml in DMEM, 10% FCS). Plates were then washed and incubated with a 1:2,500 dilution (in DMEM, 10% FCS) of a peroxidase-conjugated goat anti-mouse IgG antibody (Sigma) for 1 h at 37°C. H2O2 and o-phenylenediamine (2.5 mM each in 0.1 M phosphate-citrate buffer, pH 5.0) were then added to serve as substrate and chromogen, respectively. The enzymatic reaction (carried out at room temperature) was stopped after 30 min with 1 M H2SO4 solution containing 0.05 M Na2SO3, and the color development was measured bichromatically in the BioKinetics reader (EL 312, Bio Tek Instruments, Inc., Winooski, VT) at 490 and 630 nm. One day after transfections, COS-7 cells were transferred into six-well plates (1-2 × 105 cells/well) containing sterilized glass coverslips. About 48 h later, cells were fixed with 4% formaldehyde in PBS for 30 min at room temperature. After with binding was with DMEM containing 10% were then incubated for 2 h at 37°C with the monoclonal antibody μg/ml in DMEM, 10% FCS) or an antibody against a corresponding to the C-terminal 10 of the rat m3 muscarinic receptor by F. After washing the of antibody with cells were incubated for 1 h at 37°C with a or dilution of a goat anti-mouse or goat IgG antibody respectively. The antibody was by washing with and were on using a To the cells were with in PBS for 10 min at room M.J. 1992; Scholar). were using a confocal and were was from The rat m3 muscarinic receptor was split in all three intracellular (i1-i3) and all three extracellular loops (o2-o4) by mutagenesis techniques (Fig. 1, Table 1). To study the expression and subcellular localization of the resulting individual receptor a nine-amino acid HA-epitope tag (12Kolodziej P.A. Young R.A. Methods Enzymol. 1991; 194: 508-519Google Scholar) was added to the N of all truncated receptors Fig. 1). studies that all of this (except showed a subcellular similar to that of the wild type m3 muscarinic receptor containing an at N COS-7 cells or a of the plasma membrane from that with for in Fig. In contrast, was not found in the plasma membrane in but was in the as with cells (Fig. localization of m3 muscarinic receptor fragments. COS-7 cells were transfected with constructs coding for truncated m3 muscarinic receptor containing only the first TM Fig. 1) and and Ci3 truncated m3 muscarinic receptor containing TM VI and Fig. 1) and contained an HA-epitope tag at N Ci3 was used in studies with and and cells and were carried out as described For the detection of an antibody directed against the C-terminal 10 of the rat m3 muscarinic receptor was is of two or three independent an HA-epitope was also added to the C of two of the truncated receptor Co3 and studies with COS-7 cells transfected with the epitope-tagged of Co3 or Ci3 showed that the two be in the complex, similar to the wild type m3 receptor containing an HA-epitope at C Fig. not be determined with or not these two fragments were also into the plasma membrane. Coexpression of Co3 and Ci3 with their corresponding receptor and also not in a of the in COS-7 that the of the immunofluorescence was to the plasma membrane localization of the of Co3 and We examined the ability of an antibody by F. F. against a corresponding to the C-terminal 10 of the rat m3 muscarinic receptor to Co3 and Ci3 on the of transfected COS-7 In this C-terminal be localized to the plasma membrane for Ci3 in Fig. The of was not when Co3 and Ci3 were coexpressed with and respectively. To quantify the amount of truncated receptor fragments present in the plasma membrane, an indirect cellular ELISA protocol was developed The of this assay was by COS-7 cells transfected with wild type m3 receptor containing an HA-epitope at N experiments with cells transfected with wild type m3 receptor containing an HA-epitope at C resulted in as found with cells the of the wild type m3 receptor not the of the plasma membrane The was expressed at different receptor membrane studied in [3H]NMS saturation binding by of the amount of transfected plasmid (Fig. In ELISA experiments were carried out with COS-7 cells derived from the of cells used for the Fig. 4 that the in the ELISA studies were to receptor determined in the radioligand binding Based on this ELISA experiments were carried out with transfected with receptor fragments of the N containing an HA-epitope at their N termini (Ni1-No4; Fig. 1). with the studies described the found with were not different from determined with COS-7 cells the of the wild type m3 muscarinic receptor In contrast, of COS-7 cells with all other truncated m3 receptor fragments and that were the a and protein amount present in the plasma membrane (Fig. these are to be expressed at about the wild type receptor Open table in a new tab COS-7 cells the various m3 muscarinic receptor fragments were to bind the muscarinic In contrast, a of [3H]NMS binding be after coexpression of No3•Co3, or Ni3•Ci3 [3H]NMS binding was found after coexpression of the polypeptide pairs No2•Co2, or even at high [3H]NMS concentrations to 4 Open table in a new tab The results of the [3H]NMS saturation and competition binding studies are in Table in [3H]NMS saturation binding after coexpression of No3•Co3, or Ni3•Ci3 to about of the corresponding wild type receptor when of plasmid were used for transfections. The Ni3•Ci3 receptor and binding similar to of the wild type receptor The Ni2•Ci2 and No3•Co3 polypeptide complexes showed and respectively, for all ligands To study the various m3 receptor fragments were of G their ability to mediate stimulation of hydrolysis was examined in transfected COS-7 functional was with cells the various not only was with of the six fragment pairs examined (Ni1•Ci1, No2•Co2, and (Fig. In contrast, the No3•Co3 and Ni3•Ci3 receptor complexes were able to stimulate the of inositol to a similar maximum extent as the wild type m3 muscarinic receptor (Fig. Table The by No3•Co3 was characterized by a in (Fig. Table with the in with this polypeptide in the radioligand binding studies was able to stimulate hydrolysis in cells transfected with Ni3•Ci3 with about as with cells similar of the wild type m3 receptor (Fig. Table In competition binding studies, the Ni3•Ci3 a similar to that of the wild type receptor Open table in a new tab hydrolysis by the No3•Co3 and Ni3•Ci3 polypeptide COS-7 cells were transfected in 100-mm with epitope-tagged wild type m3 receptor μg of supplemented with μg of vector and μg of each of No3•Co3 or Ni3•Ci3 the of inositol in a fashion similar to the of the wild type m3 receptor not assays were carried out in six-well plates as described are as in in the of for to The in the coexpression experiments were not different from this is of three independent experiments, each carried out in To test the hypothesis that GPCRs consist of multiple structural the rat m3 muscarinic receptor was split in all three intracellular (i1-i3) and all three extracellular loops six polypeptide pairs (Ni1•Ci1, No2•Co2, COS-7 cells were transfected with the individual receptor fragments to study their expression and subcellular Interestingly, immunocytochemical and ELISA studies showed that all truncated receptors were present in the plasma membrane. that proper intracellular and plasma membrane insertion of GPCRs not the presence of the receptor In even as and which contain only the first two and three TM respectively, are to the plasma membrane. In to all other truncated receptor fragments the which only the first TM only be but not on the been that proper membrane of plasma membrane proteins on the of the N- and C-terminal of TM I E. Proc. Natl. Acad. Sci. U. S. A. Scholar). only the first six of the and may not contain the structural for proper plasma membrane insertion. We found that coexpression of and with their corresponding C-terminal receptor segments and resulted in a considerable of [3H]NMS binding that a TM and TM TM and TM and TM and TM respectively, is not for the of the ligand binding the Ni3•Ci3 receptor wild ligand binding the Ni2•Ci2 and No3•Co3 polypeptide complexes showed binding for all muscarinic agonists and antagonists that the and loops may indirect on the proper of the transmembrane receptor by TM I-VII) the binding of ligands as acetylcholine is to (6Dohlman H.G. Thorner J. Caron M.G. Lefkowitz R.J. Annu. Rev. Biochem. 1991; 60: 653-688Google Scholar; 23Savarese T.M. Fraser C.M. Biochem. J. 1992; 283: 1-19Google Scholar; J. Pharmacol. Sci. 1993; Scholar; 24Strader C.D. Fong T.M. Tota M.R. Underwood D. Dixon R.A.F. Annu. Rev. Biochem. 1994; 63: 101-132Google Scholar). To the of which fraction of the Ni3•Ci3, and No3•Co3 fragments is with each we carried out [3H]NMS binding studies with cells these polypeptide The in these experiments not were similar to by the of membrane homogenates [3H]NMS is a ligand that not the plasma membrane, the in Table 3 be a of the amount of polypeptide present on the the other the ELISA experiments about the amount of the receptor fragments and present in the plasma membrane. of the ELISA data be into by using the standard in Fig. and the of [3H]NMS binding to which fraction of and is with and respectively. Based on these be that of the and and of on the in a with their corresponding C-terminal receptor fragments. Interestingly, immunocytochemical studies with two of the C-terminal receptor Co3 and that these were to the even when expressed alone. The of a high antibody directed against the C of the rat m3 muscarinic receptor showed that fragments were localized to the plasma membrane. The immunological studies that N- and C-terminal m3 muscarinic receptor fragments be to the is that the No3•Co3, and Ni3•Ci3 polypeptide complexes be in the plasma membrane and in the studies showed that the No3•Co3 and Ni3•Ci3 receptor complexes were able to stimulate hydrolysis to a similar maximum extent as the wild type m3 muscarinic receptor. the by Ni3•Ci3 was characterized by an in with the wild type this polypeptide was shown to bind with wild this that the Ni3•Ci3 activate G proteins with Interestingly, a acid of the i3 of the rat m3 muscarinic receptor was not in or Co3 but was the construction of the two fragments. The that this of the i3 structural elements for receptor that a on protein The correctness of this hypothesis be studied in coexpression experiments using modified of this of the i3 In to No3•Co3 and Ni3•Ci3, the Ni2•Ci2 complex, ability to bind muscarinic ligands with high was to stimulate hydrolysis to a with findings that the of GPCRs an in proper G protein recognition and J. Scholar; H.G. Thorner J. Caron M.G. Lefkowitz R.J. Annu. Rev. Biochem. 1991; 60: 653-688Google Scholar; 23Savarese T.M. Fraser C.M. Biochem. J. 1992; 283: 1-19Google Scholar; J. J. 1993; Scholar), this that the of the is for protein In to No3•Co3, and Ni3•Ci3, coexpression of the No2•Co2, and polypeptide not in ligand binding The of functional found with be by the that is not inserted into the plasma membrane the other the of the and polypeptide to functional receptors at data strongly suggest that muscarinic receptors and, most likely, other GPCRs are composed of multiple subunits. These to be able to of each other in a fashion that with each other to a functional receptor The findings described with a plasma membrane protein are with studies on a structurally membrane not to G proteins but as a a Scholar). the present study was carried out in an in all studies on the of were in different from found in an be shown that be from individual receptor fragments resulting from of various E. H.G. J. 1983; Scholar; J. 1987; Scholar, 1992; Scholar). these findings the that the folding of and membrane proteins in two Scholar). In the individual transmembrane helices are the The helices in with each other to a functional protein be that truncated of GPCRs have also been shown to be of or mutations in the receptor for which to of the receptor protein in various intracellular and extracellular be the of J. 1994; Scholar). a the to a stop site in the i3 been shown to to a of P.J. 1992; Scholar). Based on the results in this study, one may that mutant receptors for or designed to the of these mutant proteins. In we in that GPCRs are composed of multiple structural subunits. findings be of for the molecular mechanisms membrane and intracellular of plasma membrane proteins. We for and F. for with an antibody against the C of the rat m3 muscarinic receptor.
20